Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treatment and uses for CaMKII and its interaction with HDACs and calpain

Methods of treatment and uses for CaMKII and its interaction with HDACs and calpain

US Patent 7863414 · Granted Jan 4, 2011

Estimated economic value: $181,084,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of a small native peptide activator of SERCA pump for treatment of heart fai2025
Compositions and methods relating to myomaker-induced muscle cell fusion2022
ABHD5 and partial HDAC4 fragments and variants as a therapeutic approach for the2022
NURR1 activation in the treatment of metabolic disorders and as an exercise mime2021
Functional noise floor adjustment of signal measurement device2021
Use of a small native peptide activator of SERCA pump for treatment of heart fai2021
Apoptosis signal-regulating kinase inhibitors2021
Generation and correction of a humanized mouse model with a deletion of dystroph2020
Use of a small native peptide activator of SERCA pump for treatment of heart fai2020
High efficiency reprogramming of fibroblasts into cardiomyocytes2019
Micro-RNA family that modulates extracellular matrix genes and uses thereof2019
Compositions and methods relating to myomaker-induced muscle cell fusion2019